Effects of NAT2 polymorphism on SASP pharmacokinetics in Chinese population - Ma, Jing-Jing; Liu, Cun-Gang; Li, Jin-Heng; Cao, Xiao-Mei; Sun, Sheng-Li; Yao, Xuan (Clinica chimica acta, 2009)
Keywords: Administration, Oral; Arylamine N-Acetyltransferase - genetics; Asian Continental Ancestry Group - genetics; Calibration; China; Chinese subjects; Feasibility Studies; Genetic polymorphism; Humans; Male; N-Acetyltransferase 2; Pharmacogenetics; Polymorphism, Genetic; Quality Control; Sulfapyridine - analogs & derivatives; Sulfapyridine - blood; Sulfapyridine - metabolism; Sulfapyridine - pharmacokinetics; Sulfasalazine; Sulfasalazine - administration & dosage; Sulfasalazine - blood; Sulfasalazine - metabolism; Sulfasalazine - pharmacokinetics; Young Adult; China; AcSP; Cl/F; Cmax; Pharmacogenetics; m/m; SASP; SA; RA; AUC; k e; SNK; w/m; NAT2; Chinese subjects; Tmax; Genetic polymorphism; IA; N-Acetyltransferase 2; t 1/2; Sulfasalazine; V d; SP; w/w